The Impact of Non-Compliance to a Standardized Risk-Adjusted Protocol on Recurrence, Progression, and Mortality in Non-Muscle Invasive Bladder Cancer.

Cancer Manag Res · 2021 · PMC8020126 · PMID 33833577

Europe PMC DOI

hedged sentence

0.0750

closest p · 1.5× alpha

0.0750

boldest claim

The sentences

did not reach statistical significanceP =0.075so close (0.05 < p ≤ 0.1)

This finding did not reach statistical significance ( P =0.075) because all deceased patients were non-compliant ( Figure 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.